WhaleWatch
Sign inGet started
Smart Money Alert
Natco Pharma Limited logo

Natco Pharma Limited

DecreasedSAST
NATCOPHARMPharmaceuticalsMarket Cap₹15K Cr
Stake
1.98% → 1.95%
Deal value
₹4.42 Cr
Shares
50,000
Trade date
24 Aug 2026
Since alert−8.1%₹853.80 → ₹785.05
Nifty 50−4.3%
DU
Durga Devi Nannapaneni
Promoter
The move

Promoter Durga Devi Nannapaneni sold 50,000 shares of Natco Pharma in an off-market transaction, decreasing her stake from 1.98% to 1.95%.

About Natco Pharma Limited
Visit stock

A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.

Get the next move the moment it happens.
Follow the investors and Natco Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Natco Pharma Limited shareholdersAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Natco Pharma Limited
More moves in Natco Pharma Limited
Tata Mutual FundNew position
Tata Mutual Fund raised its stake in Natco Pharma to 1.03%, up from under 1% in the prior period, now holding 18,38,744 shares.
16 Oct 2026
Read more
LICNew position
LIC initiated a new position in Natco Pharma, acquiring 40,09,317 shares, representing a 2.24% stake. The investment is valued at ₹385.54 Cr based on Natco Pharma's share price of ₹961.60.
10 Jul 2026
Read more
SANJAY NANNAPANENI and SATYA VANI NANNAPANENIDecreased
Sanjay Nannapaneni and Satya Vani Nannapaneni sold 1.15 lakh shares of Natco Pharma for ₹11.63 Cr at ₹1017.31 apiece, reducing the promoter group's stake from 0.13% to 0.09%.
9 Mar 2026
Read more
See all moves